Florence Rabian

Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies

Reuben Benjamin, Charlotte Graham, Deborah Yallop et al. · The Lancet · 2020 · 344 citations · Full text

Hematological Malignancy, Cell Therapy, Transplantation +9

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia

Régis Peffault de Latour, Austin Kulasekararaj, Simona Iacobelli et al. · New England Journal of Medicine · 2022 · 265 citations · Full text

Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia

Marie-Émilie Dourthe, Florence Rabian, Karima Yakouben et al. · Leukemia · 2021 · 145 citations

Hematological Malignancy, Lymphoid Neoplasia, Transplantation +10

UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial

Reuben Benjamin, Nitin Jain, Marcela V. Maus et al. · The Lancet Haematology · 2022 · 121 citations · Full text

Hematological Malignancy, Lymphoid Neoplasia, Cell Therapy +10

Outcomes in patients treated with chimeric antigen receptor T-cell therapy who were admitted to intensive care (CARTTAS): an international, multicentre, observational cohort study

Élie Azoulay, Pedro Castro, Adel Maamar et al. · The Lancet Haematology · 2021 · 91 citations

Clinical Immunology, Translational Medicine, Cell Therapy +8